Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2006 May;188(10):3543–3550. doi: 10.1128/JB.188.10.3543-3550.2006

Studies of the CobA-Type ATP:Co(I)rrinoid Adenosyltransferase Enzyme of Methanosarcina mazei Strain Gö1

Nicole R Buan , Kimberly Rehfeld 1, Jorge C Escalante-Semerena 1,*
PMCID: PMC1482872  PMID: 16672609

Abstract

Although methanogenic archaea use B12 extensively as a methyl carrier for methanogenesis, little is known about B12 metabolism in these prokaryotes or any other archaea. To improve our understanding of how B12 metabolism differs between bacteria and archaea, the gene encoding the ATP:co(I)rrinoid adenosyltransferase in Methanosarcina mazei strain Gö1 (open reading frame MM3138, referred to as cobAMm here) was cloned and used to restore coenzyme B12 synthesis in a Salmonella enterica strain lacking the housekeeping CobA enzyme. cobAMm protein was purified and its initial biochemical analysis performed. In vitro, the activity is enhanced 2.5-fold by the addition of Ca2+ ions, but the activity was not enhanced by Mg2+ and, unlike the S. enterica CobA enzyme, it was >50% inhibited by Mn2+. The CobAMm enzyme had a KmATP of 3 μM and a KmHOCbl of 1 μM. Unlike the S. enterica enzyme, CobAMm used cobalamin (Cbl) as a substrate better than cobinamide (Cbi; a Cbl precursor); the β phosphate of ATP was required for binding to the enzyme. A striking difference between CobASe and CobAMm was the use of ADP as a substrate by CobAMm, suggesting an important role for the γ phosphate of ATP in binding. The results from 31P-nuclear magnetic resonance spectroscopy experiments showed that triphosphate (PPPi) is the reaction by-product; no cleavage of PPPi was observed, and the enzyme was only slightly inhibited by pyrophosphate (PPi). The data suggested substantial variations in ATP binding and probably corrinoid binding between CobASe and CobAMm enzymes.


Bioinformatics analyses of archaeal genome sequences readily identify putative orthologs of B12 biosynthetic genes found in Salmonella enterica (28, 44). However, positive identification of gene function requires in vivo and in vitro analyses. To facilitate the latter, we have taken advantage of our extensive collection of S. enterica strains lacking specific functions needed for coenzyme B12 synthesis. We have successfully used this approach to identify archaeal nonorthologous replacements of bacterial B12 biosynthetic functions needed for the assembly of the nucleotide loop of coenzyme B12 (25, 44, 47, 48, 50, 51) and for the transport of corrinoids across the membrane (49).

In these studies we turned our attention to the archaeal enzyme responsible for the conversion of vitamin B12 to its coenzymic form, adenosyl-B12 (AdoB12, AdoCbl). Not all archaeal genomes contain orthologs of the S. enterica cobA gene, which in this bacterium and in Escherichia coli encodes the housekeeping enzyme responsible for attaching the adenosyl moiety from ATP to the cobalt ion of the corrin ring (13, 24, 41). In S. enterica, the cobA gene is constitutively expressed, and the activity of the CobASe enzyme is required for de novo biosynthesis of the corrin ring (13) and for salvaging complete and incomplete corrinoids from the environment (39-41). In other words, the broad specificity of the CobASe enzyme allows S. enterica to salvage a broad spectrum of corrinoids from its environment and to solve the need for corrinoid adenosylation during de novo corrin ring biosynthesis.

The genome of the methanogenic archaeon Methanosarcina mazei strain Gö1 contains a putative cobA ortholog (ORF MM3138), which we hypothesized might play physiological roles similar to those of the CobASe enzyme.

MATERIALS AND METHODS

Plasmid construction.

The M. mazei cobA+ gene (locus tag MM3138) was PCR amplified from Methanosarcina mazei strain Gö1 genomic DNA by using the primers “M.mazei CobA pT7-7 fwd” (5′-TACGGGCCATATGGCCGGTGGCATGGTATAC-3′) and “M.mazei CobA pT7-7 rev” (5′-GGATCCGTGATCAATATTCAAGTCCTTCCCTTGCAG-3′). The PCR fragment was digested with NdeI/BamHI and ligated into cloning vector pT7-7 (42), yielding plasmid pMmaCOBA4.

Analysis of growth behavior.

Strains and plasmids used in the present study are listed in Table 1. The ability of the M. mazei cobA+ gene to complement a Salmonella cobA strain was assessed in 96-well plates (Becton/Dickinson). Strains were grown in lysogenic broth (LB) (4) (2 ml) overnight cultures containing the appropriate drug at 37°C. Plates contained no-carbon E (NCE) minimal medium (3), trace minerals (1), MgSO4 (1 mM), and NH4Cl (30 mM). When cells were grown on glycerol as the sole carbon and energy source, the medium was supplemented with glycerol (30 mM), 5,6-dimethylbenzimidazole in dimethyl sulfoxide (300 μM), and dicyanocobinamide [(CN)2Cbi, 200 nM]. When cells were grown on ethanolamine, the medium was supplemented with ethanolamine hydrochloride (30 mM, pH 7), methionine (0.5 mM), and hydroxocobalamin (HOCbl, 200 nM). Samples (10 μl) of overnight LB cultures containing the appropriate drug were used to inoculate each well containing 190 μl of fresh medium. Plates were incubated in a BioTek plate reader at 37°C with maximum aeration.

TABLE 1.

Strains and plasmids

Strain or plasmida Genotype Source or referenceb
Strains
    E. coli JE3892 BL21(λDE3) Fdcm ompT hsdS(rB mB) gal λ(DE3) New England Biolabs
    S. enterica
        TR6583 metE205 ara-9 cobA+ K. Sanderson via J. Roth
        JE1293* cobA366::Tn10d(cat+)
        JE7180* cobA366::Tn10d(cat+) eut1141eutT)
        JE7954* cobA366::Tn10d(cat+) eut1141eutT)/pMmaCOBA4 This study
        JE7955* cobA366::Tn10d(cat+) eut1141eutT)/pT7-7 This study
Plasmids
    pMmaCOBA4 bla+M. mazei strain Gö1 PT7cobAMm This study
    pT7-7 bla+ 42
a

*, Derivative of strain TR6583.

b

Unless otherwise indicated, all strains are part of the laboratory collection.

Isolation of the CobAMm protein.

Plasmid pMmaCOBA4 was transformed into E. coli BL21(λDE3) for overexpression (17). Fresh transformants were grown overnight in 10 ml of LB plus ampicillin (100 μg/ml). The latter cultures were used to inoculate three 1.5-liter flasks containing LB plus ampicillin. Cells were shaken at 37°C until late log phase, when gene overexpression was induced with 0.5 mM IPTG (isopropyl-β-d-thiogalactopyranoside), and the flasks were shifted to 25°C. Cells were harvested the next day by centrifugation at 4°C for 20 min at 5,000 × g in a Beckman Coulter Avanti-J-20 XPI centrifuge fitted with a JLA 8.1000 rotor. The cell paste was resuspended in 40 ml of 50 mM glycine buffer (pH 9.5) containing 5 mM dithiothreitol (DTT), and 1 mM phenylmethylsulfonyl fluoride. Cell slurry was passed twice through a French pressure cell at 1,250 kPa to ensure breakage. Cell extracts were centrifuged at 4°C for 1 h at 43,667 × g in a Beckman Coulter Avanti-J-25I centrifuge fitted with a JA 25.50 rotor. The supernatant was decanted and treated with a few crystals of DNase for 20 min at room temperature and dialyzed twice for 30 min against 750 ml of 50 mM glycine buffer (pH 9.5) containing 5 mM DTT. After treatment, cell extracts were halved and purified independently.

Native CobAMm protein was purified by using an ÄKTA Explorer fast-protein liquid chromatograph (Pharmacia). First, each half of the treated cell extract was loaded onto two 5-ml HiTrap Q Fast Flow columns (Amersham Biosciences) connected in a series. After a 20-ml wash with buffer A1 (50 mM glycine [pH 9.5], 5 mM DTT), CobAMm protein was eluted in a linear gradient to 30% buffer B1 (50 mM glycine [pH 9.5], 1 M NaCl, 5 mM DTT) over 200 ml (0 to 300 mM NaCl). Fractions containing CobAMm were pooled and dialyzed overnight against 50 mM glycine (pH 9.5), 4 M NaCl, and 5 mM DTT. After dialysis, each sample was applied to two 5-ml HiTrap Phenyl High Performance columns (Amersham Biosciences) in a series. After a 20-ml wash with buffer A2 (50 mM glycine [pH 9.5], 4 M NaCl, 5 mM DTT), CobAMm was eluted with a linear gradient to 100% buffer B2 (50 mM glycine [pH 9.5], 4 M ethylene glycol, 5 mM DTT) over 100 ml. Fractions containing CobAMm were pooled and dialyzed against buffer A1. The sample was concentrated to 10 ml by using an Amicon Centricon with a YM10 membrane (cutoff = 10 kDa). Each sample was purified by using an 8-ml Source 15Q column (Amersham Biosciences) After a 16-ml wash with buffer A1, CobAMm was eluted with a linear gradient to 15% B1 over 80 ml (0 to 150 mM NaCl). The purity of CobAMm protein was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (23), followed by Coomassie blue staining (32). Fractions enriched for CobAMm protein were concentrated by using an Amicon Centricon device with a YM10 membrane and dialyzed against 10 mM glycine buffer (pH 9.5). Glycerol was added to dialyzed CobAMm protein to a final concentration of 10% (vol/vol), and samples were stored at −80°C until used.

Adenosyltransferase assays.

Assays were performed in sealed quartz cuvettes flushed with oxygen-free N2. Reactions contained 0.2 M Tris-Cl buffer (pH 8, 37°C), 50 μM HOCbl, 500 μM ATP, 500 μM CaCl2, 2.5 mM Ti(III)citrate reductant (26), and 2.5 μM CobAMm protein. The reaction rate was monitored by determining the decrease in absorbance at 388 nm (9, 20). For flavodoxin-dependent assays, Ti(III)citrate was replaced by FldAH6 protein (C terminus H6-tagged flavodoxin, 2 μM), Fpr protein [ferredoxin(flavodoxin):NADPH oxidoreductase, 2 μM], and NADPH (500 μM) (16). The amount of adenosylcobalamin (AdoCbl) synthesized after 30 min was monitored by determining the decrease in absorbance at 525 nm after photolysis for 10 min on ice as described previously (41).

31P-NMR spectroscopy.

A 10-ml corrinoid adenosylation reaction mixture containing Ti3+ citrate (3 mM), ATP (100 μM), HOCbl (100 μM), CaCl2 (500 μM), and CobAMm protein (5 μM) in 0.2 M Tris-Cl buffer (pH 8, 37°C) was incubated for 2 h at 37°C. After incubation, EGTA was added to 20 mM, reactions were concentrated in a SpeedVac overnight at room temperature, and 100% D2O was added to 6%. Orthophosphate, pyrophosphate, and triphosphate standards were added to 100 μM when indicated. The data were collected at the regional nuclear magnetic resonance (NMR) facility at Madison at the University of Wisconsin-Madison.

RESULTS

The protein encoded by M. mazei Gö1 open reading frame (ORF) MM3138 functions as an ATP:co(I)rrinoid adenosyltransferase in vivo.

The predicted amino acid sequence of the M. mazei Gö1 MM3138 protein (referred to herein as CobAMm) was 31% identical to the S. enterica CobA protein (Fig. 1). This suggested that the MmCobA amino acid sequence could be the ATP:co(I)rrinoid adenosyltransferase of this methanogenic archaeon. The presence of a CobA-type, short ATP-binding P-loop motif (2) (Fig. 1) strengthened this hypothesis. Noteworthy differences between the primary amino acid sequences of these proteins were the absence in CobAMm of residues 4 to 25 of CobASe. A deletion of these residues in CobASe severely impairs the interactions between CobASe and flavodoxin A (8). Three other shorter stretches of amino acids in CobASe were missing in CobAMm, while a 15-residue stretch present in CobAMm was absent in CobASe (Fig. 1). We speculate that, based on these differences, the three-dimensional structures of these proteins may differ significantly. Efforts to solve the three-dimensional crystal structure of CobAMm are under way.

FIG. 1.

FIG. 1.

Alignment of CobA from S. enterica with archaeal homologs. The primary amino acid sequence of CobASe is 31% identical and 52% similar to that of CobAMm. The dark-shaded box indicates the P-loop ATP-binding motif, while the light-gray box indicates regions of conservation. Asterisks denote absolutely conserved amino acid residues. Sen, Salmonella enterica; Mma, Methanosarcina mazei strain Gö1; Mac, Methanosarcina acetivorans strain C2A; Has, Halobacterium salinarum strain NRC-1; Pae, Pyrobaculum aerophilum; Pab, Pyrococcus abyssi; Pfu, Pyrococcus furiosus; Pho, Pyrococcus horikoshii; Tac, Thermoplasma acidophilum; Tvo, Thermoplasma volcanium. Alignment was generated by using DNA* software package v.1.66 (DNASTAR, Inc.) without adjustments.

To demonstrate the function of CobAMm in vivo, ORF MM3138 was amplified from M. mazei strain Gö1 DNA, and the amplification product was cloned into overexpression vector pT7-7 (42); the resulting plasmid was named pMmaCOBA4 (Table 1). Plasmid pMmaCOBA4 was transformed into S. enterica metE cobA eutT strain JE7180, and the ability of the resulting strain (JE7954) to grow under conditions that required low or high levels of AdoCbl was assessed. A control strain was constructed by transforming the cloning vector pT7-7 into strain JE7180, yielding strain JE7955.

Low Cbl requirement test.

Low Cbl levels (1 nM) satisfy the methionine requirement of an S. enterica metE strain during growth on glucose or glycerol (45, 49). Strains lacking Cbl-independent methionine synthase (MetE) methyltransferase activity methylate homocysteine via the Cbl-dependent methionine synthase (MetH) enzyme (18). During aerobic growth on glycerol, a culture of strain JE7954 (metE cobA eutT/pMmacobA+) reached the same cell density as a culture of strain TR6583 (metE cobA+ eutT+) (Fig. 2A, solid symbols), but the rate of growth of strain TR6583 (cobA+) was faster by a factor of 2. The positive effect of CobAMm on the conversion of cobinamide to AdoCbl was substantial compared to the growth behavior of control strains (Fig. 2A, open symbols).

FIG. 2.

FIG. 2.

cobA+Mm compensates for the lack of cobASe under conditions that require low levels of AdoCbl for growth. (A) Growth behavior of S. enterica strains grown in minimal medium containing glycerol as sole carbon and energy source. (B) Growth in minimal medium containing ethanolamine as sole carbon and energy source. Derivatives of strain JE7180 [cobA366::Tn10d(cat+) eut1141eutT)] carrying plasmids pMmaCOBA4 cobA+Mm (strain JE7954) or pT7-7 (VOC, strain JE7955) were used to investigate CobAMm function in vivo. Strains TR6583 (cobA+ eut+) and JE1293 [cobA366::Tn10d(cat+)] were used as controls. VOC, vector-only control.

High Cbl requirement test.

To grow on ethanolamine as a sole carbon and energy source, S. enterica must synthesize AdoCbl before the EutR regulatory protein (29) can activate transcription of the ethanolamine utilization (eut) operon (9, 34) that encodes functions needed to catabolize ethanolamine (6, 7, 21, 30, 31, 36, 37). Growth of S. enterica strain JE7954 [cobA eut (eutT)/pMmaCOBA4 cobA+Mm] on ethanolamine requires high levels of AdoCbl (≥150 nM [6]). As shown in Fig. 2B, the CobAMm enzyme did not compensate for the lack of CobASe enzyme during growth of strain JE7954 on ethanolamine as sole carbon and energy source. There are several possible explanations for why the CobAMm enzyme did not support growth on ethanolamine as efficiently as the CobASe enzyme did. For example, CobAMm may not have been expressed at a high enough level to support wild-type growth, it may not have been stably maintained, or its interactions with flavodoxin may have been suboptimal. At present, no data favoring any of these possibilities is available, however. Nevertheless, the data presented in Fig. 2A support the conclusion that the CobAMm protein has activity that can attach the adenosyl upper ligand to the corrin ring of cobinamide in vivo, allowing its conversion to AdoCbl and the use of the latter in methionine synthesis.

Initial biochemical characterization of CobAMm.

CobAMm enzyme was purified from E. coli. We obtained 8 mg of CobAMm protein per liter of culture grown under the conditions described above; CobAMm was calculated to be 88% homogeneous (Fig. 3). In vitro corrinoid adenosyltransferase assays with CobAMm protein were performed by using published protocols for assaying CobASe activity (9).

FIG. 3.

FIG. 3.

CobAMm protein purity. CobAMm protein was isolated as described in Materials and Methods. After Coomassie blue staining, protein purity was quantified by using a Fotodyne.

Reductant and pHopt.

Potassium borohydride (KBH4) was tested as a reducing agent in lieu of Ti3+ citrate but, for unknown reasons, it was detrimental to the activity of the enzyme. CobAMm activity was assayed at various pH values. Under conditions where Mg2+ ion concentration was saturating for CobASe, the highest rate of AdoCbl synthesis occurred at pH 8 (e.g., at pH 7.5 the specific activity is 0.75, at pH 8 the specific activity is 1.02, and at pH 8.5 specific activity is 0.94 nmol min−1 mg−1).

Cation requirement.

We tested the effect of metal ions on CobAMm activity under conditions that used Ti3+ citrate as a reductant at pH 7. Ca2+ ions stimulated CobAMm activity 2.5-fold over activities measured in reaction mixtures where metal salts were not added. Co2+, Ni2+, and Zn2+ ions stimulated the CobAMm activity 1.75-, 1.5-, and 1.25-fold, respectively. Surprisingly, and unlike CobASe, CobAMm activity was substantially inhibited by Mn2+ ions (60% reduction) relative to the no-additions control, and Mg2+ ions did not significantly improve enzyme activity (Fig. 4). In light of the above results, Ca2+ ions were present at 0.5 mM in all subsequent assays.

FIG. 4.

FIG. 4.

CobAMm enzyme activity is enhanced by the addition of Ca2+ ions. Various metal salts were tested for their effect on CobAMm activity in vitro. Salts were added to the reaction mixture containing 0.2 M Tris-Cl buffer (pH 8, 37°C), CobAMm (2 μm), ATP (100 mM), HOCbl (50 μM), and Ti(III) citrate (2.5 mM) as a reductant.

Kinetic parameters and corrinoid substrate preference.

We used the optimized conditions described above to gain insights into the affinity of CobAMm for its substrates and the velocity of the reaction. From the data shown in Fig. 5 we calculated a KmATP of 3 μM when Cbl was held at 0.05 mM. When the ATP was held at 0.5 mM and the concentration of Cbl was varied, we calculated a KmCbl of 0.9 μM and a Vmax of 3 nmol min−1.

FIG. 5.

FIG. 5.

Kinetic analysis of the CobAMm-catalyzed reaction. (A) HOCbl was held constant at 0.05 mM, while the concentration of ATP was varied. Vmax was determined to be 3 nmol of AdoCbl formed min−1 mg−1; the apparent KmATP was calculated at 3 μM. (B) The ATP concentration was held constant at 0.50 mM, while the HOCbl concentration was varied. Vmax was 3 nmol of AdoCbl formed min−1 mg−1, and the apparent KmHOCbl was calculated to be 1 μM.

While the kinetic analyses were performed with HOCbl as substrate, the uncertain physiological role of CobAMm in vivo prompted us to test the ability of the enzyme to use Cbi as substrate since it lacks the lower 5,6-dimethylbenzimidazole ligand. Under substrate saturation conditions, the specific activities when Cbl or Cbi was used as a substrate was 1.56 or 0.90 nmol min−1 mg−1, respectively. Therefore, under the conditions of the in vitro assay, CobAMm preferred Cbl over Cbi as a substrate.

Nucleoside triphosphate substrate.

The activity of CobAMm as a function of different nucleoside triphosphates was determined. The data in Fig. 6A were plotted relative to the activity of the enzyme when ATP was the substrate. Unlike CobASe, the base of nucleoside substrates tested had a significant negative effect on CobAMm activity. The most dramatic effect was obtained with CTP. Although CTP is a better substrate than ATP for CobaSe (15), it was a poor substrate for CobAMm. A second difference between CobASe and CobAMm was observed when deoxynucleoside triphosphates (dNTPs) were used. dNTPs are not substrates for CobASe (15), but CobAMm used dNTPs as substrates, and its activity with dCTP was equivalent to the activity measured with ATP. The most striking difference between CobASe and CobAMm was observed with ADP. Although ADP is not a substrate for CobASe (15), CobAMm retained 37% of its activity when ADP substituted for ATP. This result suggested that the γ phosphate was likely the primary phosphate for ATP coordination.

FIG. 6.

FIG. 6.

CobAMm protein interacts with the 2′-OH and the γ phosphate of ATP but is not inhibited by PPPi. (A) Specificity of the CobAMm enzyme for its nucleoside triphosphate substrate. When added, ADP was present in the reaction mixture at 500 μM. The reaction rate for a mixture containing ATP was 2.3 nmol of AdoCbl min−1 ± 0.1. Ado, adenosine. (B) When added to the reaction mixture, PPPi, PPi, or Pi was present at 1 mM. The reaction rate for a mixture with no additions was 1.8 nmol of AdoCbl min−1.

Triphosphate is the by-product of the CobAMm reaction.

In an effort to identify the phosphate by-product of the CobAMm reaction, we tested the sensitivity of the enzyme to triphosphate (PPPi), pyrophosphate (PPi), or orthophosphate (Pi) (all at 1 mM, Fig. 6B). CobAMm was not inhibited by the presence of PPPi and in fact was slightly stimulated (Fig. 6B). This stimulatory effect was not due to a simple increase in ionic strength; the addition of up to 10 mM NaCl to the assays had no effect on the rate of catalysis (data not shown). PPi was a weak inhibitor (28% decrease in specific activity), and Pi had no significant effect. CobASe is strongly inhibited by PPPi and has been shown to release PPPi as a reaction by-product (15). In light of this information, we hypothesized that CobAMm probably cleaved PPPi to PPi and Pi as part of the catalytic cycle. We addressed this possibility using 31P-NMR spectroscopy (Fig. 7). The 31P-NMR spectrum showed an accumulation of PPPi in the reaction mixture, no increase in Pi signal, and no detectable PPi peak. In Fig. 7A, the signal proximal to Cbl was not identified. We speculate that it was likely the result of ion coordination by the phosphate moiety in the nucleotide loop of Cbl. In Fig. 7C and D, the doublet proximal to the α-PPPi signal was not identified and may arise from ion interactions with PPPi. On the basis of this information we concluded that CobAMm does not cleave PPPi to PPi and Pi. The absence of inhibition by PPPi and only weak inhibition by PPi may reflect the importance of purine ring coordination in substrate binding to the enzyme active site.

FIG. 7.

FIG. 7.

31P-NMR analysis of CobAMm reaction by-products. Strong signals for the β phosphate of ATP (centered at −21.51 ppm) and PPPi (centered at −22.39 ppm) were observed after incubation of CobAMm with its substrates. No signal was detected from PPi at −7.41 ppm. (A) Complete reaction mixture; (B) ATP standard; (C) PPPi standard; (D) mixture of ATP, PPPi, PPi, Pi, and HOCbl.

DISCUSSION

We presented here experimental evidence supporting the annotation of an archaeal gene encoding a protein with CobA-type ATP:co(I)rrinoid adenosyltransferase activity. To reflect these findings, we propose that ORF MM3138 from the methanogenic archaeon Methanosarcina mazei strain Gö1 be hereafter referred to as cobA.

Potential differences between archaeal and bacterial CobA enzymes.

Although CobAMm and CobASe may have evolved from a common ancestor (Fig. 1), there could be significant differences between the mechanisms of catalysis used by these enzymes. Proper positioning of the ATP substrate in the active site of CobASe is critical to catalysis. However, biochemical data suggest that CobASe and CobAMm may not bind ATP the same way. For example, the absolute requirement of CobASe for the 2′-OH of the ribose in ATP is not shared by CobAMm, suggesting that CobAMm presents the target (5′-C) for the nucleophilic attack by Co(I) by different means. The role of the base of NTPs is also significantly different between the archaeal and bacterial enzymes. Although CobAMm uses ITP, GTP, CTP, and UTP as substrates, CobASe can use them more efficiently. In fact, CobASe prefers CTP and UTP over ATP (15). It is therefore likely that CobAMm interacts with the purine ring more than CobASe, which only forms a single H-bond between the carbonyl oxygen of Asn37 and the amino group of adenine (2). Therefore, in CobAMm, positioning of the 5′-C may be mediated by interactions with the γ phosphate and the purine ring rather than by interactions with the α and β phosphates and the 2′-OH as in CobASe. This difference in ATP binding was unexpected considering the relatedness of the two enzymes.

CobASe and CobAMm may interact differently with its corrinoid substrate. Many of these differences may be due to the absence of an N-terminal helix in CobAMm. Residues 1 to 23 of CobASe form an N-terminal α helix that closes over the occupied active site (2). CobAMm has only 10 residues before the ATP-binding P-loop motif (Fig. 1). A plausible explanation would be that the higher apparent Km of CobAMm for Cbl and the sluggishness of the enzyme may be attributable to the absence of the N-terminal helix. It is important to note, however, that an N-terminal truncation of CobaSe results in a more active enzyme, as long as the substrates are present at saturating levels (8), suggesting that an enzyme lacking the N-terminal helix undergoes faster substrate binding and product release. The Vmax for CobAMm is also ca. 17% of that of CobASe (3 versus 18 nmol of AdoCbl min−1 mg−1). This decreased CobAMm activity may be a consequence of the overexpression/purification procedures or suboptimal in vitro assay conditions, or it may represent a true difference in enzyme catalysis. Additional work is required to determine the reasons for this important difference.

The marked difference in the ability between CobAMm and CobaSe in the use ADP as a substrate suggests significant variations in how these enzymes bind ATP. The three-dimensional structure of CobASe complexed with MgATP and Cbl shows the Mg2+ ion octahedrally coordinated by two nonbridging phosphate oxygens from the α- and β-phosphates, the hydroxyl group of Thr42, a carboxylate oxygen of Glu128 and two water molecules. This coordination is similar to that observed in other enzymes (e.g., F1ATPase), with some differences. The three-dimensional structure of CobAMm complexed with substrates is needed to better understand how CobAMm binds ATP, its cation, and its corrinoid substrate. Efforts to obtain a three-dimensional structure of CobAMm are currently under way.

CobAMm may be a Ca2+-dependent ATP:co(I)rrinoid adenosyltransferase.

ATP-binding enzymes use divalent cations to coordinate the triphosphate and partially shield the negative charge. The same is true for cobalamin adenosyltransferases. It is known that CobASe prefers Mn2+ but will use Mg2+ ions in vitro (40). A second class of ATP:co(I)balamin adenosyltransferase found in S. enterica is encoded by the pduO gene of the 1,2-propanediol utilization (pdu) operon. The PduO enzyme prefers Mg2+ as a cation (19, 20). We were very surprised to see that Ca2+ ions stimulated activity 2.5-fold, but Mg2+ ions did not stimulate activity, and Mn2+ ions inhibited the enzyme (Fig. 4). In these assays, CobAMm was not treated with chelating agents, so the presence of any accessory bound cations cannot be ruled out. However, the 2.5-fold stimulation of enzyme activity was specific for Ca2+. There are only a few examples in the literature of CaATP binding enzymes, e.g., the human heat shock protein 70 (hHsp70) (27, 35), β-actin (10), and synapsin I (14, 46). It is important to note that hHsp70 and β-actin have been crystallized complexed with MgATP and seem to require a divalent cation for ATP binding, whereas synapsin I specifically requires CaATP for enzyme activity (5, 14). Although it is possible that CobAMm requires Ca2+ ions for structural integrity and not ATP binding, a possibility exists that CobAMm may be a unique CaATP:co(I)rrinoid adenosyltransferase.

Can Salmonella FldA serve as the electron shuttle protein for CobAMm?

In S. enterica, the physiological electron transfer protein for the CobA enzyme is flavodoxin (FldA) (16). Although the Methanosarcina genomes contain flavodoxin homologs, corrinoid adenosyltransferases in these organisms may use one of several ferredoxins or other unknown means to generate co(I)rrinoid substrates for CobAMm. The inability of CobAMm to support the growth of S. enterica on ethanolamine may be a reflection of poor coupling between S. enterica FldA and CobAMm proteins. If SenFldA is indeed the reductant for CobAMm, their coupling may be insufficient to support growth on ethanolamine. However, even if poor, such coupling satisfies the Cbl requirement of the cell for methionine synthesis (Fig. 2A). In vitro assays using possible reductants from M. mazei are needed to address the question of co(II)rrin reduction in archaea.

Why does Methanosarcina need an adenosyltransferase?

Methanogenic archaea use pseudo-B12, 5-hydroxybenzimidazolylcobamide, or cobalamin as a methyl donor (11, 12, 22, 33, 38), and sequenced genomes contain homologs of B12-dependent ribonucleotide reductases (43). At present, it is unclear what role the CobAMm enzyme plays in vivo. It is possible that, like CobASe, CobAMm is needed to attach the adenosyl upper ligand to an intermediate of the corrin ring biosynthetic branch of the pathway, to adenosylate corrinoids from its environment that may or may not contain a lower ligand, or both (47, 50). Very little is known about B12-dependent metabolism in archaea. Biochemical data suggest salvaging of incomplete corrinoids and/or de novo biosynthesis proceeds through an adenosylated intermediate (47). However, details of the de novo biosynthetic pathway, transport, and precursor salvaging in archaea remain to be elucidated.

Acknowledgments

This study was supported in part by NIH grant GM40313 to J.C.E.-S. N.R.B. was supported in part by a Howard Hughes Predoctoral Fellowship.

REFERENCES

  • 1.Balch, W. E., and R. S. Wolfe. 1976. New approach to the cultivation of methanogenic bacteria: 2-mercaptoethanesulfonic acid (HS-CoM)-dependent growth of Methanobacterium ruminantium in a pressurized atmosphere. Appl. Environ. Microbiol. 32:781-791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bauer, C. B., M. V. Fonseca, H. M. Holden, J. B. Thoden, T. B. Thompson, J. C. Escalante-Semerena, and I. Rayment. 2001. Three-dimensional structure of ATP:corrinoid adenosyltransferase from Salmonella typhimurium in its free state, complexed with MgATP, or complexed with hydroxycobalamin and MgATP. Biochemistry 40:361-374. [DOI] [PubMed] [Google Scholar]
  • 3.Berkowitz, D., J. M. Hushon, H. J. Whitfield, J. Roth, and B. N. Ames. 1968. Procedure for identifying nonsense mutations. J. Bacteriol. 96:215-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brautigam, C. A., Y. Chelliah, and J. Deisenhofer. 2004. Tetramerization and ATP binding by a protein comprising the A, B, and C domains of rat synapsin I. J. Biol. Chem. 279:11948-11956. [DOI] [PubMed] [Google Scholar]
  • 6.Brinsmade, S. R., and J. C. Escalante-Semerena. 2004. The eutD gene of Salmonella enterica encodes a protein with phosphotransacetylase enzyme activity. J. Bacteriol. 186:1890-1892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brinsmade, S. R., T. Paldon, and J. C. Escalante-Semerena. 2005. Minimal functions and physiological conditions required for growth of Salmonella enterica on ethanolamine in the absence of the metabolosome. J. Bacteriol. 187:8039-8046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Buan, N. R., and J. C. Escalante-Semerena. 2005. Computer-assisted docking of flavodoxin with the ATP:co(I)rrinoid adenosyltransferase (CobA) enzyme reveals residues critical for protein-protein interactions but not for catalysis. J. Biol. Chem. 280:40948-40956. [DOI] [PubMed] [Google Scholar]
  • 9.Buan, N. R., S. J. Suh, and J. C. Escalante-Semerena. 2004. The eutT gene of Salmonella enterica encodes an oxygen-labile, metal-containing ATP:corrinoid adenosyltransferase enzyme. J. Bacteriol. 186:5708-5714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chik, J. K., U. Lindberg, and C. E. Schutt. 1996. The structure of an open state of beta-actin at 2.65 Å resolution. J. Mol. Biol. 263:607-623. [DOI] [PubMed] [Google Scholar]
  • 11.DiMarco, A. A., T. A. Bobik, and R. S. Wolfe. 1990. Unusual coenzymes of methanogenesis. Annu. Rev. Biochem. 59:355-394. [DOI] [PubMed] [Google Scholar]
  • 12.Eisenreich, W., and A. Bacher. 1991. Biosynthesis of 5-hydroxybenzimidazolylcobamid (factor III) in Methanobacterium thermoautotrophicum. J. Biol. Chem. 266:23840-23849. [PubMed] [Google Scholar]
  • 13.Escalante-Semerena, J. C., S.-J. Suh, and J. R. Roth. 1990. cobA function is required for both de novo cobalamin biosynthesis and assimilation of exogenous corrinoids in Salmonella typhimurium. J. Bacteriol. 172:273-280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Esser, L., C. R. Wang, M. Hosaka, C. S. Smagula, T. C. Sudhof, and J. Deisenhofer. 1998. Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J. 17:977-984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fonseca, M. V., N. R. Buan, A. R. Horswill, I. Rayment, and J. C. Escalante-Semerena. 2002. The ATP:co(I)rrinoid adenosyltransferase (CobA) enzyme of Salmonella enterica requires the 2′-OH group of ATP for function and yields inorganic triphosphate as its reaction by-product. J. Biol. Chem. 277:33127-33131. [DOI] [PubMed] [Google Scholar]
  • 16.Fonseca, M. V., and J. C. Escalante-Semerena. 2001. An in vitro reducing system for the enzymic conversion of cobalamin to adenosylcobalamin. J. Biol. Chem. 276:32101-32108. [DOI] [PubMed] [Google Scholar]
  • 17.Inoue, H., H. Nojima, and H. Okayama. 1990. High efficiency transformation of Escherichia coli with plasmids. Gene 96:23-28. [DOI] [PubMed] [Google Scholar]
  • 18.Jeter, R. M., and J. R. Roth. 1987. Cobalamin (vitamin B12) biosynthetic genes of Salmonella typhimurium. J. Bacteriol. 169:3189-3198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Johnson, C. L., M. L. Buszko, and T. A. Bobik. 2004. Purification and initial characterization of the Salmonella enterica PduO ATP:cob(I)alamin adenosyltransferase. J. Bacteriol. 186:7881-7887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Johnson, C. L., E. Pechonick, S. D. Park, G. D. Havemann, N. A. Leal, and T. A. Bobik. 2001. Functional genomic, biochemical, and genetic characterization of the Salmonella pduO gene, an ATP:cob(I)alamin adenosyltransferase gene. J. Bacteriol. 183:1577-1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kofoid, E., C. Rappleye, I. Stojiljkovic, and J. Roth. 1999. The 17-gene ethanolamine (eut) operon of Salmonella typhimurium encodes five homologues of carboxysome shell proteins. J. Bacteriol. 181:5317-5329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kräutler, B., J. Moll, and R. K. Thauer. 1987. The corrinoid from Methanobacterium thermoautotrophicum (Marburg strain): spectroscopic structure analysis and identification as Cob-cyano-5′-hydroxybenzimidazolyl-cobamide (factor III). Eur. J. Biochem. 162:275-278. [DOI] [PubMed] [Google Scholar]
  • 23.Laemmli, U. K. 1970. Cleavage and structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. [DOI] [PubMed] [Google Scholar]
  • 24.Lundrigan, M. D., and R. J. Kadner. 1989. Altered cobalamin metabolism in Escherichia coli btuR mutants affects btuB gene regulation. J. Bacteriol. 171:154-161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Maggio-Hall, L. A., K. R. Claas, and J. C. Escalante-Semerena. 2004. The last step in coenzyme B12 synthesis is localized to the cell membrane in bacteria and archaea. Microbiology 150:1385-1395. [DOI] [PubMed] [Google Scholar]
  • 26.Monticello, D. J., and R. N. Costilow. 1981. Purification and partial characterization of proline dehydrogenase from Clostridium sporogenes. Can. J. Microbiol. 27:942-948. [DOI] [PubMed] [Google Scholar]
  • 27.Osipiuk, J., M. A. Walsh, B. C. Freeman, R. I. Morimoto, and A. Joachimiak. 1999. Structure of a new crystal form of human Hsp70 ATPase domain. Acta Crystallogr. D Biol. Crystallogr. 55:1105-1107. [DOI] [PubMed] [Google Scholar]
  • 28.Rodionov, D. A., A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand. 2003. Comparative genomics of the vitamin B12 metabolism and regulation in prokaryotes. J. Biol. Chem. 278:41148-41159. [DOI] [PubMed] [Google Scholar]
  • 29.Roof, D. M., and J. R. Roth. 1992. Autogenous regulation of ethanolamine utilization by a transcriptional activator of the eut operon in Salmonella typhimurium. J. Bacteriol. 174:6634-6643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Roof, D. M., and J. R. Roth. 1988. Ethanolamine utilization in Salmonella typhimurium. J. Bacteriol. 170:3855-3863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Roof, D. M., and J. R. Roth. 1989. Functions required for vitamin B12-dependent ethanolamine utilization in Salmonella typhimurium. J. Bacteriol. 171:3316-3323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sasse, J. 1991. Detection of proteins, p. 10.6.1-10.6.8. In F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N.Y. [Google Scholar]
  • 33.Scherer, P., V. Höllriegl, C. Krug, M. Bokel, and P. Renz. 1984. On the biosynthesis of 5-hydroxybenzimidazolylcobamide (vitamin B12-factor III) in Methanosarcina barkeri. Arch. Microbiol. 138:354-359. [Google Scholar]
  • 34.Sheppard, D. E., J. T. Penrod, T. Bobik, E. Kofoid, and J. R. Roth. 2004. Evidence that a B12-adenosyl transferase is encoded within the ethanolamine operon of Salmonella enterica. J. Bacteriol. 186:7635-7644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sriram, M., J. Osipiuk, B. Freeman, R. Morimoto, and A. Joachimiak. 1997. Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain. Structure 5:403-414. [DOI] [PubMed] [Google Scholar]
  • 36.Starai, V. J., J. Garrity, and J. C. Escalante-Semerena. 2005. Acetate excretion during growth of Salmonella enterica on ethanolamine requires phosphotransacetylase (EutD), and acetate recapture depends on acetyl-CoA synthetase activity. Microbiology 151:3793-3801. [DOI] [PubMed] [Google Scholar]
  • 37.Stojiljkovic, I., A. J. Bäumler, and F. Heffron. 1995. Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutj eutH gene cluster. J. Bacteriol. 177:1357-1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Stupperich, E., I. Steiner, and H. J. Eisinger. 1987. Substitution of Coa-(5-hydroxybenzimidazolyl)cobamide (factor III) by vitamin B12 in Methanobacterium thermoautotrophicum. J. Bacteriol. 169:3076-3081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Suh, S.-J. 1994. The role of CobA in adenosylation of corrinoids in Salmonella typhimurium. Ph.D. thesis. University of Wisconsin-Madison, Madison.
  • 40.Suh, S.-J., and J. C. Escalante-Semerena. 1993. Cloning, sequencing, and overexpression of cobA which encodes ATP:corrinoid adenosyltransferase in Salmonella typhimurium. Gene 129:93-97. [DOI] [PubMed] [Google Scholar]
  • 41.Suh, S.-J., and J. C. Escalante-Semerena. 1995. Purification and initial characterization of the ATP:corrinoid adenosyltransferase encoded by the cobA gene of Salmonella typhimurium. J. Bacteriol. 177:921-925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tabor, S. 1990. Expression using the T7 RNA polymerase/promoter system, p. 16.2.1.-16.2.11. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Wiley Interscience, New York, N.Y. [Google Scholar]
  • 43.Tauer, A., and S. A. Benner. 1997. The B12-dependent ribonucleotide reductase from the archaebacterium Thermoplasma acidophila: an evolutionary solution to the ribonucleotide reductase conundrum. Proc. Natl. Acad. Sci. USA 94:53-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Thomas, M. G., and J. C. Escalante-Semerena. 2000. Identification of an alternative nucleoside triphosphate: 5′-deoxyadenosylcobinamide phosphate nucleotidyltransferase in Methanobacterium thermoautotrophicum DH. J. Bacteriol. 182:4227-4233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Van Bibber, M., C. Bradbeer, N. Clark, and J. R. Roth. 1999. A new class of cobalamin transport mutants (btuF) provides genetic evidence for a periplasmic binding protein in Salmonella typhimurium. J. Bacteriol. 181:5539-5541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wang, C. R., L. Esser, C. S. Smagula, T. C. Sudhof, and J. Deisenhofer. 1997. Identification, expression, and crystallization of the protease-resistant conserved domain of synapsin I. Protein Sci. 6:2264-2267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Woodson, J. D., and J. C. Escalante-Semerena. 2004. CbiZ, an amidohydrolase enzyme required for salvaging the coenzyme B12 precursor cobinamide in archaea. Proc. Natl. Acad. Sci. USA 101:3591-3596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Woodson, J. D., R. F. Peck, M. P. Krebs, and J. C. Escalante-Semerena. 2003. The cobY gene of the archaeon Halobacterium sp. strain NRC-1 is required for de novo cobamide synthesis. J. Bacteriol. 185:311-316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Woodson, J. D., A. A. Reynolds, and J. C. Escalante-Semerena. 2005. ABC transporter for corrinoids in Halobacterium sp. strain NRC-1. J. Bacteriol. 187:5901-5909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Woodson, J. D., C. L. Zayas, and J. C. Escalante-Semerena. 2003. A new pathway for salvaging the coenzyme B12 precursor cobinamide in archaea requires cobinamide-phosphate synthase (CbiB) enzyme activity. J. Bacteriol. 185:7193-7201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zayas, C. L., J. D. Woodson, and J. C. Escalante-Semerena. 2006. The cobZ gene of Methanosarcina mazei Gö1 encodes the non-orthologous replacement of the a-ribazole-5′-phosphate phosphatase (CobC) enzyme of Salmonella enterica. J. Bacteriol. 188:2740-2743. [DOI] [PMC free article] [PubMed]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES